Controversy swirls around adipose-derived cell therapies for reparative medicine
Challenging the U.S. Food and Drug Administration's current approach to evaluating and approving adipose-based cell therapies used in reparative medicine, a group of researchers proposes a new path forward that focuses on ...
Feb 19, 2020
0
0